…
Exploring the Unique Features of the Samsung Galaxy Gear S
Smartwatches have seen quite an evolution over the years in both functionality and design. In both categories, none quite stands out like the wireless wearable hands-on…
Dr Simon Sung Joins Fox Chase Cancer Center
Simon Sung, MD
Fox Chase Cancer Center is pleased to announce the hiring of Simon Sung, MD, as an associate professor in the Department of Pathology.
Prior to…
Comparison of Quizartinib and Midostaurin in FLT3+ AML
Kateryna Fedorov, MD, assistant professor, hematology-oncology, Vanderbilt University Medical Center, discusses disease factors and patient characteristics to consider when deciding between treatment……
Maximize Your Grass’s Potential with the SMONET RLM1000: A Blend of Innovation and Nature
Maintaining a lush, pristine lawn often feels like a laborious task, requiring time, effort, and expertise. However, with the advent of cutting-edge technology, the age-old chore…
Treatment of HR+/HER2– Breast Cancer with CDK4/6 Inhibitors: A Discussion on Evolution
Rita Nanda, MD, associate professor, medicine, director, Breast Oncology Program, University of Chicago, UChicago Medicine, discusses the evolution of treatment with CDK4/6 inhibitors in patients……
Embracing Modern Living in Rural Areas: Tips for a Rural Revival
In an era defined by urbanization and technological advancement, the allure of rural living is experiencing a renaissance. People are increasingly drawn to the tranquility, space,…
Researcher predicts James Webb telescope will soon find evidence of extraterrestrial life
Lisa Kaltenegger, who currently directs the Carl Sagan Institute at Cornell, recently told The Telegraph that announcements of alien life discovery are imminent and that the…
Focal Therapy for Prostate Cancer Treatment
Ruben Olivares, MD, urologic surgeon, associate professor, urology, Glickman Urological Institute, Cleveland Clinic, discusses what sets focal therapy apart from localized radiation therapy in the……
“Cabozantinib Shows Potential in Treating Advanced Adrenocortical Carcinoma”
FRIDAY, April 26, 2024 (HealthDay News) — For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in…